Evidence map›Paper›PMID 18174382›Full record

ArticleBlood2008

Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.

Sri Vidya Kondadasula, Julie M Roda, Robin Parihar, Jianhua Yu, Amy Lehman, Michael A Caligiuri, Susheela Tridandapani, Richard W Burry, William E Carson

Open access · greenAbstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Noncatalytic Bruton's tyrosine kinase activates PLCγThe Journal of biological chemistry · 2020
    Article
  9. Review
  10. Review
  11. NK Cell-Fc Receptors Advance Tumor Immunotherapy.Journal of clinical medicine · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sri Vidya KondadasulaDepartment of Molecular Virology, Immunology, and Medical Genetics, Human Cancer Genetics program, The Arthur G. James Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH, USA.
Julie M Roda
Robin Parihar
Jianhua Yu
Amy Lehman
Michael A Caligiuri
Susheela Tridandapani
Richard W Burry
William E Carson
Cancer Genetics (United States) · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

TWO SIGNAL REQUIREMENT FOR NATURAL KILLER IMMUNITYP01CA095426 · NCI · OHIO STATE UNIVERSITY · PI CALIGIURI, MICHAEL A · 2002 to 2016
$29.6M
NCI NIH HHS P01 CA095426NCI NIH HHS P01 CA95426
6 · The paper itself

Abstract

Natural killer (NK) cells express an activating receptor for the Fc portion of IgG (FcgammaRIIIa) that mediates interferon (IFN)-gamma production in response to antibody (Ab)-coated targets. We have previously demonstrated that NK cells activated with interleukin-12 (IL-12) in the presence of immobilized IgG secrete 10-fold or more higher levels of IFN-gamma as compared with stimulation with either agent alone. We examined the intracellular signaling pathways responsible for this synergistic IFN-gamma production. NK cells costimulated via the FcR and the IL-12 receptor (IL-12R) exhibited enhanced levels of activated STAT4 and Syk as compared with NK cells stimulated through either receptor alone. Extracellular signal-regulated kinase (ERK) was also synergistically activated under these conditions. Studies with specific chemical inhibitors revealed that the activation of ERK was dependent on the activation of PI3-K, whose activation was dependent on Syk, and that sequential activation of these molecules was required for NK cell IFN-gamma production in response to FcR and IL-12 stimulation. Retroviral transfection of ERK1 into primary human NK cells substantially increased IFN-gamma production in response to immobilized IgG and IL-12, while transfection of human NK cells with a dominant-negative ERK1 abrogated IFN-gamma production. Confocal microscopy and cellular fractionation experiments revealed that FcgammaRIIIa and the IL-12R colocalized to areas of lipid raft microdomains in response to costimulation with IgG and IL-12. Chemical disruption of lipid rafts inhibited ERK signaling in response to costimulation and significantly inhibited IFN-gamma production. These data suggest that dual recruitment of FcgammaRIIIa and the IL-12R to lipid raft microdomains allows for enhanced activation of downstream signaling events that lead to IFN-gamma production.

Indexed as

CholesterolEnzyme ActivationHumansImmunoglobulin GInterferon-gammaInterleukin-12Intracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesKiller Cells, NaturalMembrane MicrodomainsMitogen-Activated Protein Kinase 3p38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProtein TransportProtein-Tyrosine KinasesCholesterolFCGR3A protein, humanImmunoglobulin GInterferon-gammaInterleukin-12Intracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein Kinase 3p38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProtein Kinase InhibitorsProtein-Tyrosine KinasesProto-Oncogene Proteins c-aktReceptors, IgGReceptors, Interleukin-12STAT4 Transcription FactorSyk KinaseSYK protein, human

Identifiers

PMID18174382
PMCPMC2288725
OpenAlexW2043642585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.